4d pharma (4d pharma) Price-to-Tangible-Book : (As of Jun. 05, 2024)

View and export this data going back to 2021. Start your Free Trial

What is 4d pharma Price-to-Tangible-Book?

As of today (2024-06-05), 4d pharma's share price is $0.0001. 4d pharma's Tangible Book per Share of Dec. 2021 for the quarter that ended in Dec. 2021 was $0.00. Hence, 4d pharma's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for 4d pharma's Price-to-Tangible-Book or its related term are showing as below:

During the past 8 years, 4d pharma's highest Price to Tangible Book Ratio was 12.17. The lowest was 0.00. And the median was 6.66.

LBPWQ's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.78
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, 4d pharma's share price is $0.0001. 4d pharma's Book Value per Sharefor the quarter that ended in Dec. 2021 was $0.00. Hence, 4d pharma's P/B Ratio of today is .

4d pharma Price-to-Tangible-Book Historical Data

The historical data trend for 4d pharma's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma Price-to-Tangible-Book Chart

4d pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Price-to-Tangible-Book

Get a 7-Day Free Trial

4d pharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
Price-to-Tangible-Book	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of 4d pharma's Price-to-Tangible-Book

For the Biotechnology subindustry, 4d pharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4d pharma's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4d pharma's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where 4d pharma's Price-to-Tangible-Book falls into.

4d pharma Price-to-Tangible-Book Calculation

4d pharma's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2021 )
	=	0.0001	/
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

4d pharma Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of 4d pharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

4d pharma (4d pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (OTCPK:LBPWQ) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ

Website

https://www.4dpharmaplc.com

4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.